Related Experiment Video
Updated: Jun 30, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
HNF1B-MODY (MODY-5): a rare form of diabetes with multisystemic features-two case reports
Tânia Carvalho1,2, Mariana Lavrador1, Joana Saraiva1,2
1Serviço de Endocrinologia, Diabetes e Metabolismo da Unidade Local de Saúde de Coimbra, Coimbra, Portugal.
Introduction:
Maturity-Onset Diabetes of the Young (MODY) is a rare monogenic form of diabetes characterized by early onset and autosomal dominant inheritance. MODY-5, caused by HNF1B gene mutations, accounts for <5% of MODY cases and often presents with renal abnormalities and genitourinary malformations.
Case Presentation:
We describe two patients with HNF1B-related MODY confirmed by heterozygous 17q12 microdeletions. The first case, a 29-year-old woman, presented with diabetes, hypertension, bilateral renal cysts, mild chronic kidney disease (CKD), hypomagnesemia, mild liver enzyme elevations, and a complex Müllerian anomaly requiring surgical correction. She has maintained excellent metabolic control on metformin alone, with no diabetic complications after four years of follow-up. The second case, a 40-year-old man, had a history of diabetes, neonatal left nephrectomy for cystic dysplasia, CKD stage G3bA2, persistent liver enzyme elevation, dorsal pancreatic agenesis, hypomagnesemia, hyperuricemia, mild cognitive impairment, and infertility. He initially achieved good glycemic control with a combination of insulin, metformin, liraglutide, and dapagliflozin, though control subsequently fluctuated. To date, microalbuminuria remains his only diabetes-related complication.
Conclusions:
These cases underscore the broad phenotypic spectrum of MODY 5 and highlight the importance of considering HNF1B mutations in young-onset diabetes associated with renal or genitourinary anomalies. Hypomagnesemia and abnormal liver function tests are additional features that may guide suspicion. Early recognition and genetic confirmation are essential for tailored management, complication surveillance, and family screening.
More Related Videos
05:44Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
Published on: May 17, 2024
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations
Type I Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type I Diabetes I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...